These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 455738)

  • 1. Effect of the angiotensin II antagonist saralasin on plasma aldosterone concentration and on blood pressure before and during sodium depletion in normal subjects.
    Agabiti-Rosei E; Brown JJ; Brown WC; Fraser R; Trust PM; Lever AF; Morton JJ; Robertson JI
    Clin Endocrinol (Oxf); 1979 Mar; 10(3):227-34. PubMed ID: 455738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of saralasin, an angiotensin II antagonist, on blood pressure and the renin-angiotensin-aldosterone system in normal and hypertensive subjects.
    Brown JJ; Brown WC; Fraser R; Lever AF; Morton JJ; Robertson JI; Rosei EA; Trust PM
    Aust N Z J Med; 1976 Aug; 6(3 Suppl):48-52. PubMed ID: 1071403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of the angiotensin II antagonist saralasin on blood pressure and plasma aldosterone in man in relation to the prevailing plasma angiotensin II concentration.
    Brown JJ; Brown WC; Fraser R; Lever AF; Morton JJ; Robertson JI; Rosei EA; Trust PM
    Prog Biochem Pharmacol; 1976; 12():230-41. PubMed ID: 1019166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of 1-sar-8-ala-angiotensin II on arterial pressure, renin and aldosterone in hypertension.
    Fagard R; Lijnen P; Amery A; Reybrouck T
    Contrib Nephrol; 1978; 11():175-8. PubMed ID: 699588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of angiotensin II blockade by saralasin (1-Sar-8-Ala-angiotensin II) in normal man.
    Ibsen H; Kappelgaard AM; Nielsen MD; Giese J
    Eur J Clin Pharmacol; 1978 Nov; 14(3):171-6. PubMed ID: 729612
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of blockade of angiotensin II on blood pressure, renin and aldosterone in cirrhosis.
    Schroeder ET; Anderson GH; Goldman SH; Streeten DH
    Kidney Int; 1976 Jun; 9(6):511-9. PubMed ID: 940284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of sar1 ala8 angiotensin II (saralasin) on plasma aldosterone in hypertensive patients.
    Donker AJ; van Hoogdalem P; Pratt JJ; Leenen FH
    Acta Med Scand; 1979; 205(3):207-12. PubMed ID: 425848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of angiotensin II blockade by saralasin in normal man.
    Noth RH; Tan SY; Mulrow PJ
    J Clin Endocrinol Metab; 1977 Jul; 45(1):10-5. PubMed ID: 874056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin II and not sodium status is the major determinant of the agonistic/antagonistic balance of saralasin's actions.
    Fagard R; Amery A; Lijnen P
    Clin Sci (Lond); 1980 Dec; 59 Suppl 6():75s-78s. PubMed ID: 7004740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of an angiotensin antagonist (saralasin) on arterial pressure and plasma aldosterone in hemodialysis-resistant hypertensive patients.
    Mimran A; Shaldon S; Barjon P; Mion C
    Clin Nephrol; 1978 Feb; 9(2):63-7. PubMed ID: 639368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Saralasin-induced changes of blood pressure, renin and aldosterone in essential and renal hypertension (author's transl)].
    Beyer J; Liebau G; Steiner B; Hayduk K
    Klin Wochenschr; 1978 Sep; 56(17):859-64. PubMed ID: 713415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of two angiotensin II analogues on blood pressure, plasma aldosterone concentration, plasma renin activity and creatinine clearance in normal subjects on different sodium intakes.
    Hata T; Ogihara T; Mikami H; Nakamaru M; Mandai T; Kumahara Y
    Eur J Clin Pharmacol; 1980 Oct; 18(4):295-9. PubMed ID: 7002566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of angiotensin II and of an angiotensin II analogue (Sar1-Ile8-angiotensin II) on blood pressure, plasma aldosterone and plasma renin activity in the dog.
    Beckerhoff R; Uhlschmid G; Vetter W; Armbruster H; Nussberger J; Reck G; Schmied U; Siegenthaler W
    Clin Sci Mol Med Suppl; 1975 Jun; 2():41s-44s. PubMed ID: 1077788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of the specific angiotensin antagonist (Sar1) (Ala8) angiotensin II on blood pressure and the renin-angiotensin system in the conscious pregnant ewe and fetus.
    Broughton Pipkin F; O'Brien PM
    Am J Obstet Gynecol; 1978 Sep; 132(1):7-15. PubMed ID: 696788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin II and sodium as determinants of the agonistic--antagonistic balance of saralasin's actions.
    Fagard R; Amery A; Lijnen P
    Clin Sci (Lond); 1981 Apr; 60(4):377-85. PubMed ID: 7018793
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of saralasin on plasma aldosterone in hypertensive man.
    Brown RD; Tucker R; Tue K; Wisgerhof M; Salassa R
    J Lab Clin Med; 1978 Mar; 91(3):473-9. PubMed ID: 627750
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of angiotensin II antagonist to blood pressure, plasma renin activity and plasma aldosterone concentration in chronic renal failure (author's transl)].
    Nigawara K; Yagihashi Y; Kogawa T; Kawamata A; Yamaya K; Sugawara S; Tulachan Y; Funyu T; Eba H; Kido K; Tanaka T; Morita S; Fukushi M; Furusawa M; Terayama Y; Hirayama N
    Nihon Jinzo Gakkai Shi; 1979 Nov; 21(11):1231-42. PubMed ID: 396404
    [No Abstract]   [Full Text] [Related]  

  • 18. Changes in plasma norepinephrine after intravertebral artery infusion of saralasin in sodium depleted dogs.
    Arita M; Ueno Y; Suruda H; Mohara O; Nishio I; Masuyama Y
    Jpn Circ J; 1983 Mar; 47(3):336-41. PubMed ID: 6339771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic and pharmacodynamic studies of infusions with [Sar 1, Val5, Ala8] angiotensin II (saralasin).
    Gless KH; Bönner G; Gram N; Mann JF; Helber A; Ganten D
    Klin Wochenschr; 1978; 56 Suppl 1():97-105. PubMed ID: 732257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sodium space and intravascular volume: dietary sodium effects in cystic fibrosis and healthy adolescent subjects.
    Legris GJ; Dearborn D; Stern RC; Geiss CL; Hopfer U; Douglas JG; Doershuk CF
    Pediatrics; 1998 Jan; 101(1 Pt 1):48-56. PubMed ID: 9417150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.